SCHEMBL26281147

SCHEMBL26281147

CCCC12CCCN1CC(=C(F)F)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24272692 0.87 — —
SCHEMBL26301248 0.84 — —
SCHEMBL24649099 0.82 — —
SCHEMBL24663521 0.82 — —
SCHEMBL24649185 0.82 — —
SCHEMBL29300666 0.81 — —
SCHEMBL24663426 0.80 — —
SCHEMBL27269376 0.80 — —
SCHEMBL31491000 0.79 KRAS (0.30) —
SCHEMBL26303662 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023172737-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. (US) 2023-09-14 — — WO disclosed
WO-2023072188-A1 KRAS G12D INHIBITORS AND USE THEREOF IN MEDICINE 贝达药业股份有限公司 2023-05-04 — — WO disclosed
Send feedback